X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47) 47
infectious diseases (25) 25
microbiology (22) 22
middle aged (16) 16
male (15) 15
staphylococcal infections - microbiology (15) 15
staphylococcal infections - epidemiology (14) 14
aged (13) 13
female (12) 12
index medicus (12) 12
staphylococcus aureus (12) 12
staphylococcus aureus - drug effects (11) 11
adult (10) 10
anti-bacterial agents - pharmacology (9) 9
methicillin resistance (9) 9
microbial sensitivity tests (9) 9
pharmacology & pharmacy (9) 9
aged, 80 and over (8) 8
drug resistance, bacterial (8) 8
emergence (8) 8
mortality (8) 8
mrsa (8) 8
research (8) 8
anti-bacterial agents - therapeutic use (7) 7
australia - epidemiology (7) 7
community-acquired infections - microbiology (7) 7
immunology (7) 7
risk factors (7) 7
biochemical phenomena, metabolism, and nutrition (6) 6
community-acquired infections - epidemiology (6) 6
cross infection - epidemiology (6) 6
cross infection - microbiology (6) 6
drug resistance in microorganisms (6) 6
epidemiology (6) 6
infections (6) 6
medicine (6) 6
medicine, general & internal (6) 6
pneumonia (6) 6
staphylococcal infections - drug therapy (6) 6
staphylococcus aureus infections (6) 6
surgery (6) 6
adolescent (5) 5
australia (5) 5
bacteremia (5) 5
drug resistance (5) 5
drug resistance, microbial (5) 5
infection (5) 5
methicillin-resistant staphylococcus aureus - isolation & purification (5) 5
panton-valentine leukocidin (5) 5
prevalence (5) 5
susceptibility (5) 5
treatment outcome (5) 5
united-states (5) 5
western australia - epidemiology (5) 5
antibiotics (4) 4
antimicrobial resistance (4) 4
bacteria (4) 4
bacterial infections and mycoses (4) 4
care and treatment (4) 4
causes of (4) 4
child (4) 4
community (4) 4
drug resistance, multiple, bacterial (4) 4
electrophoresis (4) 4
epidemics (4) 4
genes (4) 4
hospitals (4) 4
infectious and parasitic diseases (4) 4
methicillin-resistant staphylococcus aureus - classification (4) 4
methicillin-resistant staphylococcus aureus - genetics (4) 4
staphylococcus aureus - isolation & purification (4) 4
strains (4) 4
surgical wound infection - prevention & control (4) 4
vancomycin resistance (4) 4
abdomen - surgery (3) 3
animals (3) 3
anti-bacterial agents - administration & dosage (3) 3
bacterial infections (3) 3
bacterial pneumonia (3) 3
ceftriaxone - therapeutic use (3) 3
child, preschool (3) 3
community-acquired infections (3) 3
cross infection, epidemiology (3) 3
cross infection, microbiology (3) 3
disease outbreaks (3) 3
dna (3) 3
electrophoresis, gel, pulsed-field (3) 3
failure (3) 3
gram-positive bacterial infections - microbiology (3) 3
health aspects (3) 3
identification (3) 3
methicillin-resistant (3) 3
methicillin-resistant staphylococcus aureus (3) 3
methicillin-resistant staphylococcus aureus - drug effects (3) 3
molecular epidemiology (3) 3
nosocomial infections (3) 3
penicillin (3) 3
phylogeny (3) 3
prevention (3) 3
prospective studies (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2010, Volume 5, Issue 1, p. e8705
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2012, Volume 7, Issue 8, p. e43037
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2011, Volume 39, Issue 3, pp. 193 - 200
Journal Article
Antimicrobial Resistance and Infection Control, ISSN 2047-2994, 03/2014, Volume 3, Issue 1, pp. 7 - 7
...Author(s): Julie Hart[sup.1], Keryn J Christiansen[sup.1,2], Rosie Lee[sup.1], Christopher H Heath[sup.1,3], Geoffrey W Coombs[sup.1,2] and J Owen Robinson[sup... 
Aus2/3-EMRSA | Health care workers | Methicillin resistant Staphylococcus aureus | Outbreak | EMRSA-15 | INFECTIOUS DISEASES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | BACTEREMIA | MICROBIOLOGY | PREVALENCE | RESISTANT STAPHYLOCOCCUS-AUREUS | Medical personnel | Drug resistance in microorganisms | Staphylococcus aureus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 5/2008, Volume 46, Issue 10, pp. 1513 - 1521
Background. Available data on the etiology of community-acquired pneumonia (CAP) in Australia are very limited. Local treatment guidelines promote the use of... 
Pathogens | Antigens | Pneumonia | Antibiotics | Etiology | Macrolides | Mortality | Articles and Commentaries | Penicillin | Sputum | Viruses | DIAGNOSIS | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RESPIRATORY VIRUSES | ADULTS | MICROBIOLOGY | IMMUNOLOGY | FAILURE | ORAL MOXIFLOXACIN | STREPTOCOCCUS-PNEUMONIAE | LEVOFLOXACIN | RESISTANCE | SEVERITY | Guideline Adherence - statistics & numerical data | Prospective Studies | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Bacteria - drug effects | Male | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Pneumonia, Viral - epidemiology | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Community-Acquired Infections - virology | Community-Acquired Infections - mortality | Viruses - isolation & purification | Pneumonia, Bacterial - microbiology | Penicillins - therapeutic use | Doxycycline - therapeutic use | Treatment Outcome | Pneumonia, Bacterial - epidemiology | Australia - epidemiology | Bacteria - isolation & purification | Ceftriaxone - therapeutic use | Adolescent | Aged | Pneumonia, Viral - mortality | Macrolides - therapeutic use | Community-Acquired Infections - microbiology | Pneumonia, Viral - virology | Care and treatment | Community-acquired infections | Bacterial pneumonia | Causes of | Research | Drug therapy, Combination
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 04/2006, Volume 184, Issue 8, pp. 384 - 388
Objective: To describe antimicrobial resistance and molecular epidemiology of methicillin‐resistant Staphylococcus aureus (MRSA) isolated in community settings... 
Microbiology | Infectious diseases | MEDICINE, GENERAL & INTERNAL | INFECTIONS | PANTON-VALENTINE LEUKOCIDIN | GENES | MRSA | NON-MULTIRESISTANT | PNEUMONIA | EMERGENCE | TRIMETHOPRIM-SULFAMETHOXAZOLE | MOLECULAR ANALYSIS | Geography | Staphylococcus aureus - genetics | Staphylococcal Infections - drug therapy | Community-Acquired Infections - epidemiology | Staphylococcus aureus - isolation & purification | Humans | Disease Outbreaks - statistics & numerical data | Australia - epidemiology | Cross Infection - drug therapy | Phenotype | Staphylococcal Infections - epidemiology | Health Surveys | Methicillin Resistance - genetics | Community-Acquired Infections - drug therapy | Cross Infection - microbiology | Staphylococcal Infections - microbiology | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology | Cross Infection - epidemiology | Staphylococcal Infections, drug therapy | Comparative Study | Community-Acquired Infections, microbiology | Staphylococcus aureus, isolation and purification | Disease Outbreaks, statistics and numerical data | Cross Infection, epidemiology | Staphylococcal Infections, epidemiology | Community-Acquired Infections, epidemiology | Cross Infection, microbiology | Methicillin Resistance, genetics | Staphylococcus aureus, genetics | Staphylococcus aureus, drug effects | Staphylococcal Infections, microbiology | Cross Infection, drug therapy | Methicillin Resistance | Australia, epidemiology | Community-Acquired Infections, drug therapy | Prevention | Development and progression | Staphylococcus aureus | Risk factors
Journal Article